Pharmacological modulation of beta-endorphin in rat peritoneal macrophages.
The neuropeptide beta-endorphin is present in cells of the immune system, i.e., lymphocytes and monocytes, and its expression can be induced by immunological stimuli. In the present study, we showed that the increase of the serotoninergic availability induces an increase of beta-endorphin concentrations in rat peritoneal macrophages that is blunted by the administration of serotonin receptor antagonists. A significant increase of beta-endorphin concentrations is also evident after blocking the dopaminergic receptors, whereas a dopaminergic agonist decreases the concentrations of the peptide. Our data are consistent with a similar modulation of beta-endorphin concentrations in central nervous system and in immune cells, e.g., rat peritoneal macrophages.
Sacerdote
P
P
Department of Pharmacology, University of Milano, Italy.
Panerai
A E
AE
D006916:5-Hydroxytryptophan / Q000494:pharmacology*; D000818:Animals; D001971:Bromocriptine / Q000494:pharmacology; D002490:Central Nervous System / Q000187:drug effects; D002997:Clomipramine / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology; D007111:Immunity, Cellular / Q000187:drug effects; D008264:Macrophages / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism; D008297:Male; D008711:Metergoline / Q000494:pharmacology; D010537:Peritoneum; D051381:Rats; D011919:Rats, Inbred Strains; D012701:Serotonin / Q000378:metabolism* / Q000502:physiology; D001615:beta-Endorphin / Q000378:metabolism*
D008711:Metergoline; D012701:Serotonin; D001971:Bromocriptine; D001615:beta-Endorphin; D006916:5-Hydroxytryptophan; D006220:Haloperidol; D002997:Clomipramine